Sarah Lonie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sarah Lonie has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
Kourosh Tavakoli
Department of Plastic Surgery, East Sydney Private Hospital, Sydney, Australia
5 shared publications- Chad Chang
Division of Plastic and Reconstructive Surgery, Department of Surgery, China Medical University Hospital, Taichung, Taiwan; Department of Plastic and Reconstructive Surgery, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
3 shared publications Juan Enrique Berner
Plastic Surgery Department, Royal Victoria Infirmary, the Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom
3 shared publicationsDamien Grinsell
Department of Plastic and Reconstructive Surgery, St.Vincent's Hospital, 41 Victoria Parade, Fitzroy, Victoria 3065, Australia; Horizon Plastic Surgery, 19 Winifred Street, Essendon, Victoria 3040, Australia
2 shared publicationsManiram Ragbir
Plastic Surgery Department, Royal Victoria Infirmary, the Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom
2 shared publicationsPhaethon Karagiannis
Department of Plastic Surgery, East Sydney Private Hospital, Sydney, Australia
2 shared publications
Latest Publications
- 18 February 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 103, 202-203
Tuned for success: Choosing the right Doppler probe for accurate flap assessment
- 18 February 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 103, 202-203
Tuned for success: Choosing the right Doppler probe for accurate flap assessment
- 13 November 2024
- Published by Elsevier in Journal of Hand and Microsurgery
- Vol. 17 (2) , 100174
Advanced Tips and Tricks for the Microvascular Coupler Anastomosis
- 13 November 2024
- Published by Elsevier in Journal of Hand and Microsurgery
- Vol. 17 (2) , 100174
Advanced Tips and Tricks for the Microvascular Coupler Anastomosis
- 24 August 2024
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 98, 44-45
Coffee, chocolate, pillows and pints of blood: Debunking the mantras and myths of microsurgery
- 24 August 2024
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 98, 44-45
Coffee, chocolate, pillows and pints of blood: Debunking the mantras and myths of microsurgery
- 6 July 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (9) , 108534
Malignant phyllodes: 10 year review of management through a sarcoma service
- 6 July 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (9) , 108534
Malignant phyllodes: 10 year review of management through a sarcoma service
- 28 May 2024
- Published by Springer Nature in European Journal of Plastic Surgery
- Vol. 47 (1) , 1-4
Breast striae in aesthetic surgery – a novel technique for management
- 28 May 2024
- Published by Springer Nature in European Journal of Plastic Surgery
- Vol. 47 (1) , 1-4
Breast striae in aesthetic surgery – a novel technique for management
- 3 April 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 48 (21) , 4342-4350
Inferolateral Pectoralis Sling Technique for Augmentation Mastopexy
Background Augmentation mastopexy remains a challenging procedure. The goal is to achieve correction of breast ptosis whilst adding implant volume, and avoid complications of premature waterfall deformity, bottoming out and further revision surgery, particularly when using smooth implants. We aim to describe and evaluate a technique to reduce implant malposition in augmentation mastopexy. Methods This is a technical description and retrospective review of a single surgeons’ cases from 2019 to 2022 of all patients who underwent 1 stage subpectoral breast augmentation mastopexy with the inferolateral pectoralis sling. Results Over the four year period, 284 patients (568 breasts) underwent augmentation mastopexy with the inferior pectoralis sling. Mean implant size was 360.7cc (range 180–625cc). There were no early complications and 6 (2.1%) patients had late minor complications, with five (1.8%) undergoing revision mastopexy with implant repositioning and 1 (0.4%) undergoing areola scar revision. 20 patients (7%) underwent an implant upsize procedure with the average volume increase being 218.5cc and the average time to upsize 13.6 months (range 6–36 months) Conclusions Use of the inferolateral pectoralis muscle sling allows successful one stage augmentation mastopexy with low complication and revision rates. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 3 April 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 48 (21) , 4342-4350
Inferolateral Pectoralis Sling Technique for Augmentation Mastopexy
Background Augmentation mastopexy remains a challenging procedure. The goal is to achieve correction of breast ptosis whilst adding implant volume, and avoid complications of premature waterfall deformity, bottoming out and further revision surgery, particularly when using smooth implants. We aim to describe and evaluate a technique to reduce implant malposition in augmentation mastopexy. Methods This is a technical description and retrospective review of a single surgeons’ cases from 2019 to 2022 of all patients who underwent 1 stage subpectoral breast augmentation mastopexy with the inferolateral pectoralis sling. Results Over the four year period, 284 patients (568 breasts) underwent augmentation mastopexy with the inferior pectoralis sling. Mean implant size was 360.7cc (range 180–625cc). There were no early complications and 6 (2.1%) patients had late minor complications, with five (1.8%) undergoing revision mastopexy with implant repositioning and 1 (0.4%) undergoing areola scar revision. 20 patients (7%) underwent an implant upsize procedure with the average volume increase being 218.5cc and the average time to upsize 13.6 months (range 6–36 months) Conclusions Use of the inferolateral pectoralis muscle sling allows successful one stage augmentation mastopexy with low complication and revision rates. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- Open Access
- 27 March 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 48 (9) , 1884
Correction: FAM–Fat Augmentation Mastopexy: A Method to Avoid Implants
- 27 March 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 48 (9) , 1884
Open AccessCorrection: FAM–Fat Augmentation Mastopexy: A Method to Avoid Implants
- 28 February 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 48 (18) , 3637-3645
FAM–Fat Augmentation Mastopexy: A Method to Avoid Implants
Background Despite high complication rates, patients persistently present for single-stage augmentation mastopexy. In empty, deflated breasts, we perform one-stage augmentation mastopexy; however, in heavy ptotic breasts, our preference is to stage the procedure with mastopexy and fat graft first. With volume from fat grafting focussing on the upper pole and cleavage areas, many of our patients avoid implants altogether. This reduces subsequent risks of waterfall deformity, implant displacement, rupture and a lifetime of implant exchanges. Objectives We aim to describe our findings and technique for reducing progression to the second stage of a two-stage augmentation mastopexy with the appropriate use of moderate to high volume of fat grafting at the primary operation. Methods This is a retrospective review of all patients who presented to the senior author (KT) requesting breast implants and requiring mastopexy, from January 2018 to December 2022. Results Over the five-year period, 137 patients were identified. Seventy-one (58%) underwent single-stage augmentation mastopexy, 55 (40.1%) underwent mastopexy with fat grafting and 11 (8.0%) underwent mastopexy with no fat grafting. Our key finding in this study is that 52 of 66 (78.8%) of planned staged patients, who underwent mastopexy with or without fat grafting, were happy with the volume attained and no longer wished to undergo further implant augmentation. Conclusion In selected patients, appropriate volume and position of fat grafting at the time of primary mastopexy can significantly obviate the need for a second stage implant (alloplastic) augmentation. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 28 February 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 48 (18) , 3637-3645
FAM–Fat Augmentation Mastopexy: A Method to Avoid Implants
Background Despite high complication rates, patients persistently present for single-stage augmentation mastopexy. In empty, deflated breasts, we perform one-stage augmentation mastopexy; however, in heavy ptotic breasts, our preference is to stage the procedure with mastopexy and fat graft first. With volume from fat grafting focussing on the upper pole and cleavage areas, many of our patients avoid implants altogether. This reduces subsequent risks of waterfall deformity, implant displacement, rupture and a lifetime of implant exchanges. Objectives We aim to describe our findings and technique for reducing progression to the second stage of a two-stage augmentation mastopexy with the appropriate use of moderate to high volume of fat grafting at the primary operation. Methods This is a retrospective review of all patients who presented to the senior author (KT) requesting breast implants and requiring mastopexy, from January 2018 to December 2022. Results Over the five-year period, 137 patients were identified. Seventy-one (58%) underwent single-stage augmentation mastopexy, 55 (40.1%) underwent mastopexy with fat grafting and 11 (8.0%) underwent mastopexy with no fat grafting. Our key finding in this study is that 52 of 66 (78.8%) of planned staged patients, who underwent mastopexy with or without fat grafting, were happy with the volume attained and no longer wished to undergo further implant augmentation. Conclusion In selected patients, appropriate volume and position of fat grafting at the time of primary mastopexy can significantly obviate the need for a second stage implant (alloplastic) augmentation. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.